Intec Pharma ltd (NTEC):企業の財務・戦略的SWOT分析

◆英語タイトル:Intec Pharma ltd (NTEC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14924
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solution to drugs that have poor solubility, poor colonic absorption or act locally in upper gastrointestinal part. Intec Pharma offers products for various therapeutic areas including the central nervous system, the cardiovascular system, and gastrointestinal and infectious diseases. It has collaborations with pharmaceutical and biopharmaceutical companies. Intec Pharma is headquartered in Jerusalem, Israel.

Intec Pharma ltd Key Recent Developments

Feb 27,2019: Intec Pharma announces fourth quarter and year End 2018 financial results
Jan 02,2019: Intec Pharma Advances Medical Cannabinoid Development Program With Dosing of First Patient in a Phase 1 Pharmacokinetic Study of Accordion Pill-THC
Dec 19,2018: Intec Pharma publishes letter to shareholders
Nov 09,2018: Intec Pharma reports third quarter 2018 financial results and corporate update
Aug 15,2018: Intec Pharma announces second quarter 2018 financial results

This comprehensive SWOT profile of Intec Pharma ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intec Pharma ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intec Pharma ltd – Key Information
Intec Pharma ltd – Overview
Intec Pharma ltd – Key Employees
Intec Pharma ltd – Key Employee Biographies
Intec Pharma ltd – Key Operational Heads
Intec Pharma ltd – Major Products and Services
Intec Pharma ltd – History
Intec Pharma ltd – Company Statement
Intec Pharma ltd – Locations And Subsidiaries
Intec Pharma ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intec Pharma ltd – Business Description
Intec Pharma ltd – Corporate Strategy
Intec Pharma ltd – SWOT Analysis
SWOT Analysis – Overview
Intec Pharma ltd – Strengths
Intec Pharma ltd – Weaknesses
Intec Pharma ltd – Opportunities
Intec Pharma ltd – Threats
Intec Pharma ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Intec Pharma ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intec Pharma ltd, Key Information
Intec Pharma ltd, Key Ratios
Intec Pharma ltd, Share Data
Intec Pharma ltd, Major Products and Services
Intec Pharma ltd, History
Intec Pharma ltd, Key Employees
Intec Pharma ltd, Key Employee Biographies
Intec Pharma ltd, Key Operational Heads
Intec Pharma ltd, Other Locations
Intec Pharma ltd, Subsidiaries
Intec Pharma ltd, Key Manufacturing facilities
Intec Pharma ltd, Key Competitors
Intec Pharma ltd, SWOT Analysis
Intec Pharma ltd, Ratios based on current share price
Intec Pharma ltd, Annual Ratios
Intec Pharma ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intec Pharma ltd, Performance Chart
Intec Pharma ltd, Ratio Charts

★海外企業調査レポート[Intec Pharma ltd (NTEC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Graftobian Makeup Company:企業の戦略・SWOT・財務情報
    Graftobian Makeup Company - Strategy, SWOT and Corporate Finance Report Summary Graftobian Makeup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Abbott Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Advicenne SA (ADVIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It p …
  • Applied DNA Sciences Inc (APDN):医療機器:M&Aディール及び事業提携情報
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company’s products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA se …
  • Horama SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Horama SA (Horama) is a biotechnology company, which develops gene therapy products based on recombinant adeno-associated virus (rAAV) vectors for the treatment of rare ophthalmic diseases, including retinopathies and maculopathies. Its pipeline gene replacement products include HORA-RPE65, …
  • Compugen Ltd (CGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Compugen Ltd (Compugen) is a drug discovery company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises CGEN-15001T, CGEN-15022, CGEN-15022, CGEN-15029, target candidates, immuno-modulatory target candidates and ADC target can …
  • Asplundh Tree Expert LLC:企業の戦略的SWOT分析
    Asplundh Tree Expert LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務分析
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Amneal Pharmaceuticals Inc (AMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Sectra AB (SECT B):企業の財務・戦略的SWOT分析
    Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • HealthSouth Corporation:企業のM&A・事業提携・投資動向
    HealthSouth Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HealthSouth Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Van Lanschot Private Banking:企業の戦略・SWOT・財務情報
    Van Lanschot Private Banking - Strategy, SWOT and Corporate Finance Report Summary Van Lanschot Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DSW Inc.:企業の戦略・SWOT・財務情報
    DSW Inc. - Strategy, SWOT and Corporate Finance Report Summary DSW Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Fibrocell Science Inc (FCSC):医療機器:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • Tchibo GmbH (Foodservice):企業の戦略・SWOT・財務情報
    Tchibo GmbH (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Tchibo GmbH (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Conn’S, Inc.:企業の戦略・SWOT・財務分析
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆